cas 2034526-10-6|| where to buy 3-(4-chloro-3-methylphenyl)-1-[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)azetidin-1-yl]propan-1-one hydrochloride

Produktname:3-(4-chloro-3-methylphenyl)-1-[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)azetidin-1-yl]propan-1-one hydrochloride

IUPAC Name:3-(4-chloro-3-methylphenyl)-1-[3-(1,2,3,4-tetrahydroisoquinolin-2-yl)azetidin-1-yl]propan-1-one hydrochloride

: CAS：2034526-10-6; Molekulare Formel：C22H26Cl2N2O; Reinheit：95%+

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2034526-10-6 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:2034526-10-6; Molekulare Formel:C22H26Cl2N2O; Schmelzpunkt:-; SMILES-Code:Cl.CC1=C(Cl)C=CC(CCC(=O)N2CC(C2)N2CCC3=C(C2)C=CC=C3)=C1; Dichte:

: Katalognummer:CM850277; Molekulargewicht:405.36; Siedepunkt:; Mdl-Nr.:; Lagerung:

: Azetidines; Azetidines are an important class of saturated four-membered nitrogen-containing heterocyclic compounds. The research hotspots related to this structure mainly focus on two aspects: one is the research of pharmaceutical chemistry; the other is related to chiral azetidines, using rigid azetidine compounds as chiral ligands for asymmetric catalytic reactions. Many nitrogen-containing heterocycles play important roles in drug structures, and in many cases small structural changes can improve ligand selectivity and pharmacokinetic properties.; Where to buy Azetidines; Where to buy ADC-Cytotoxins? Chemenu Provide Azetidines with high quality and competitive price. Contact us Now.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.